Search Within

Emily Kanaya Slotkin

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (15)
  2. Meeting Abstract (11)
Groups
  1. Pediatrics, Department of (26)
  2. Sarcoma Service (Pediatrics) (26)
  3. Sloan Kettering Institute Postdocs (26)
  4. GSK Faculty (21)
  5. Center for Hematologic Malignancies (20)
  6. Tow Center for Developmental Oncology (TCDO) (20)

More Groups

People
  1. Filemon Dela Cruz (12)
  2. Marc Ladanyi (12)
  3. Neerav Shukla (12)
  4. Julia Glade Bender (10)
  5. Michael Ortiz (10)
  6. Paul Meyers (10)

More People

Years
  1. 2024 (4)
  2. 2023 (1)
  3. 2022 (7)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (4)
  3. Clinical Cancer Research (4)
  4. Pediatric Blood and Cancer (3)
  5. Nature Communications (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. American Association for Cancer Research (10)
  2. American Society of Clinical Oncology (7)
  3. Wiley Periodicals, Inc (3)
  4. Nature Publishing Group (2)
  5. Cell Press (1)
  6. Nature Research (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Patient-driven discovery, therapeutic targeting, and post-clinical validation of a novel AKT1 fusion-driven cancer
    Journal Article

    Slotkin, E. K.; Diolaiti, D.; Shukla, N. N.; Dela Cruz, F. S.; Clark, J. J.; Gundem, G.; Yellapantula, V. D.; Levine, M. F.; You, D.; Ma, P.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Noninvasive molecular profiling by circulating cell-free DNA in pediatric solid tumors
    Meeting Abstract

    Kothari, P.; Slotkin, E.; Yang, J.; Stewart, C.; Gedvilaite, E.; Berger, M.; Ladanyi, M.; Shukla, N.; Modak, S.; Tsui, D.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • Modeling of oncogenic chromosomal translocations of aggressive fusion-positive sarcomas by CRISPR-Cas9 genomic engineering
    Meeting Abstract

    Spraggon, L.; Martelotto, L.; Hmeljak, J.; Hitchman, T.; Wang, J.; Wang, L.; Slotkin, E.; Fan, P. D.; Reis-Filho, J.; Ladanyi, M.
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Generation of conditional oncogenic chromosomal translocations using CRISPR–Cas9 genomic editing and homology-directed repair
    Journal Article

    Spraggon, L.; Martelotto, L. G.; Hmeljak, J.; Hitchman, T. D.; Wang, J.; Wang, L.; Slotkin, E. K.; Fan, P. D.; Reis-Filho, J. S.; Ladanyi, M.
    Journal of Pathology (2017)

    Fulltext@MSK | Save
  • Therapeutic targeting of sarcomas driven by EWSR1 fusion oncogenes by modulation of the fusion oncogene pre-mRNA
    Meeting Abstract

    Slotkin, E.; de Stanchina, E.; Cartegni, L.; Ladanyi, M.; Spraggon, L.
    Cancer Research (2016)

    Fulltext@MSK | Save